Vimarsana
Biggest News Aggregation in the World

Later Stage Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Later Stage Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Later Stage Development Today - Breaking & Trending Today

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program - Vimarsana News

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Published: December 20, 2023

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody ...

Source: pharmiweb.com
Related Topics:
Foster CityUnited StatesIsrael GeneralSan FranciscoTel AvivFlavius MartinCompugen LtdGilead Public AffairsSecurities ExchangeGilead Sciences IncTel Aviv Stock ExchangeExchange CommissionRights To Later Stage DevelopmentTerms Of The PartnershipGilead SciencesGilead Will Have Exclusive RightsLater Stage DevelopmentProtein AntibodiesTreat Various TumorUpfront PaymentNear Term Milestone PaymentTotal Deal ValueExecutive Vice PresidentAnat Cohen DayagSecurities Act
Compugen : 6K-License Agreement with Gilead and entitlement to receive a milestone payment of $10 million from AstraZeneca -December 19, 2023 at 07:24 am EST - Vimarsana News

Compugen : 6K-License Agreement with Gilead and entitlement to receive a milestone payment of $10 million from AstraZeneca -December 19, 2023 at 07:24 am EST

Published: December 19, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF...

Source: marketscreener.com
Related Topics:
United StatesTel AvivIsrael GeneralSan FranciscoFoster CityYvonne NaughtonJacquie RossMeaghan SmithFlavius MartinCompugen Ltd NasdaqTel Aviv Stock ExchangeClinical Immunotherapy ProgramGilead SciencesExchange CommissionCompugen LtdCorporate CommunicationsTerms Of The PartnershipGilead Public AffairsCommission File NumberGilead Sciences IncSecurities ExchangeCompany Registration Statement On FormRights To Later Stage DevelopmentFile NumberPrincipal Executive Offices